Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial

被引：0
|
作者：
Piccini, Jonathan P. [1 ]
Stevens, Susanna [1 ]
Lokhnygina, Yuliya [1 ]
Patel, Manesh [1 ]
Singer, Daniel [2 ]
Halperin, Jonathan [3 ]
Hankey, Graeme [4 ]
Hacke, Werner [5 ]
Becker, Richard [1 ]
Nessel, Christopher [6 ]
Mahaffey, Kenneth [1 ]
Fox, Keith [7 ]
Califf, Robert [1 ]
Breithardt, Gunter [8 ]
机构：
[1] Duke Univ, Med Ctr, Duke Clin Rsch Inst, Durham, NC USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Mt Sinai Med Ctr, New York, NY 10029 USA
[4] Royal Perth Hosp, Perth, WA 6001, Australia
[5] Heidelberg Univ, Heidelberg, Germany
[6] Johnson & Johnson Pharmaceut Rsch & Dev, Raritan, NJ USA
[7] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[8] Hosp Univ Munster, Munster, Germany
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Atrial fibrillation; Ablation; Anticoagulaion;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19281
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
    Piccini, Jonathan P.
    Stevens, Susanna R.
    Lokhnygina, Yuliya
    Patel, Manesh R.
    Halperin, Jonathan L.
    Singer, Daniel E.
    Hankey, Graeme J.
    Hacke, Werner
    Becker, Richard C.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Fox, Keith A. A.
    Califf, Robert M.
    Breithardt, Guenter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (19) : 1998 - 2006
  • [2] Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin ROCKET AF Trial
    Sherwood, Matthew W.
    Nessel, Christopher C.
    Hellkamp, Anne S.
    Mahaffey, Kenneth W.
    Piccini, Jonathan P.
    Suh, Eun-Young
    Becker, Richard C.
    Singer, Daniel E.
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Berkowitz, Scott D.
    Fox, Keith A. A.
    Patel, Manesh R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (21) : 2271 - 2281
  • [3] OUTCOMES OF TEMPORARY INTERRUPTIONS OF RIVAROXABAN OR WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ROCKET AF TRIAL
    Sherwood, Matthew W.
    Hellkamp, Anne
    Patel, Manesh
    Piccini, Jonathan
    Lokhnygina, Yuliya
    Douketis, James
    Becker, Richard
    Mahaffey, Kenneth
    Fox, Keith
    Califf, Robert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E316 - E316
  • [4] OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL
    Balla, Somasekhara R.
    Cyr, Derek
    Lokhnygina, Yuliya
    Becker, Richard
    Berkowitz, Scott
    Breithardt, Guenter
    Califf, Robert
    Fox, Keith
    Hacke, Werner
    Halperin, Jonathan
    Hankey, Graeme
    Mahaffey, Kenneth
    Nessel, Christopher
    Piccini, Jonathan
    Singer, Daniel
    Patel, Manesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A371 - A371
  • [5] OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND SIGNIFICANT VALVULAR LESIONS: COMPARISON OF THE EFFECTS OF RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL
    Breithardt, Guenter
    Berkowitz, Scott
    Baumgartner, Helmut
    Hellkamp, Anne
    Piccini, Jonathan
    Stevens, Susanna
    Lokhnygina, Yuliya
    Patel, Manesh
    Halperin, Jonathan
    Singer, Daniel
    Hankey, Graeme
    Hacke, Werner
    Becker, Richard
    Nessel, Christopher
    Mahaffey, Kenneth
    Califf, Robert
    Fox, Keith
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E339 - E339
  • [6] Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Subgroup Analysis of the ROCKET AF Trial
    Halperin, Jonathan L.
    Bloomgarden, Zachary
    Hellkamp, Anne
    Lokhnygina, Yuliya
    Patel, Manesh
    Becker, Richard
    Breithardt, Gunter
    Hacke, Werner
    Hankey, Graeme
    Nessel, Christopher
    Singer, Daniel
    Berkowitz, Scott
    Califf, Robert
    Fox, Keith
    Mahaffey, Kenneth
    CIRCULATION, 2012, 126 (21)
  • [7] Outcomes of rivaroxaban versus warfarin in women and men with nonvalvular atrial fibrillation: results from the ROCKET AF trial
    Dixon, B.
    Hellkamp, A. S.
    Lokhnygina, Y.
    Piccini, J. P.
    Berkowitz, S. D.
    Mahaffey, K. W.
    Becker, R. C.
    Breithardt, G.
    Fox, K. A. A.
    Patel, M. R.
    EUROPEAN HEART JOURNAL, 2015, 36 : 744 - 744
  • [8] Rivaroxaban vs. warfarin with concomitant aspirin use in patients with atrial fibrillation: findings from the ROCKET AF trial
    Shah, R.
    Hellkamp, A. S.
    Berkowitz, S. D.
    Breithardt, G.
    Fox, K. A. A.
    Mahaffey, K. W.
    Nessel, C. C.
    Piccini, J. P.
    Singer, D. E.
    Patel, M. R.
    EUROPEAN HEART JOURNAL, 2015, 36 : 345 - 345
  • [9] Risk of Stroke Outcomes in Atrial Fibrillation Patients Treated with Rivaroxaban and Warfarin
    Milentijevic, Dejan
    Lin, Jennifer H.
    Connolly, Nancy
    Chen, Yen-Wen
    Kogan, Emily
    Shrivastava, Shubham
    Sjoeland, Erik
    Alberts, Mark J.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (05):
  • [10] Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study
    Hori, Masatsugu
    Matsumoto, Masayasu
    Tanahashi, Norio
    Momomura, Shin-ichi
    Uchiyama, Shinichiro
    Goto, Shinya
    Izumi, Tohru
    Koretsune, Yukihiro
    Kajikawa, Mariko
    Kato, Masaharu
    Ueda, Hitoshi
    Iwamoto, Kazuya
    Tajiri, Masahiro
    CIRCULATION JOURNAL, 2012, 76 (09) : 2104 - 2111
12345